AI embryo selection uses deep learning algorithms to rank embryos by implantation potential, reducing subjective grading variability and potentially improving per-transfer pregnancy rates by ~10%. It does NOT replace PGT-A genetic testing. Most valuable when choosing between multiple good-quality blastocysts for single embryo transfer. Adds $500–$2,000 per cycle.
Key Takeaways
AI reduces embryologist subjectivity — the same embryo gets the same score every time, unlike human graders who disagree 20-30% of the time
Clinical evidence suggests ~10% improvement in per-transfer success, but cumulative rates across all embryos are similar — AI helps pick the best one first
AI analyzes morphology, not genetics — it cannot replace PGT-A for detecting chromosomal abnormalities
Most useful when you have multiple good embryos and want to maximize single-embryo transfer success
How AI Is Changing IVF Embryo Selection
Traditionally, embryologists evaluate embryos under a microscope, grading them based on visual criteria — cell number, symmetry, fragmentation, blastocyst expansion. It's a skilled job, but it's inherently subjective. Two experienced embryologists can grade the same embryo differently, and a "beautiful" looking embryo doesn't always implant.
AI embryo selection tools use deep learning algorithms trained on thousands (sometimes hundreds of thousands) of embryo images and their outcomes to predict which embryos have the highest implantation potential. The technology is moving fast — and the clinical evidence is finally catching up.
The Major AI Platforms in 2026
| Platform | Approach | Training Data | Key Claims | FDA Status |
|---|---|---|---|---|
| ERICA (Vitrolife) | Time-lapse morphokinetics + deep learning | 115,000+ embryos | Ranks embryos by implantation probability | CE marked, FDA cleared |
| iDAScore (Vitrolife) | Fully automated blastocyst scoring | 200,000+ embryos | Removes subjective grading variability | CE marked |
| Life Whisperer (Presagen) | Single-image AI analysis | Multiple clinic datasets | Works without time-lapse equipment | CE marked, FDA breakthrough |
| CHLOE (Fairtility) | Continuous embryo monitoring | Real-time development tracking | Predicts blastocyst formation early | CE marked |
| Embryo Options (Alife) | Decision support platform | US clinic partnerships | Integrates with existing lab workflows | FDA cleared |
What AI Actually Does vs. What It Doesn't
It's important to separate the hype from the evidence:
What AI Does Well
- Reduces subjective variability: AI grades consistently — the same embryo gets the same score every time, unlike human graders who may disagree 20–30% of the time
- Identifies patterns invisible to human eyes: Subtle morphokinetic features (exact timing of cell divisions, movement patterns) correlate with implantation but are difficult for humans to track manually
- Speeds up decision-making: Automated scoring frees embryologists to focus on complex cases rather than routine grading
- Improves embryo ranking: Among embryos that all look "good" by traditional grading, AI can often distinguish which has the highest implantation potential
What AI Cannot Do
- Replace PGT-A: AI analyzes morphology, not genetics. It cannot detect chromosomal abnormalities (aneuploidy), which are the leading cause of implantation failure and miscarriage
- Guarantee success: Even the highest-ranked embryo may not implant due to uterine factors, immune issues, or other variables AI can't assess
- Overcome poor egg/sperm quality: AI selects the best from what's available — it doesn't improve the underlying gamete quality
- Account for endometrial receptivity: Implantation requires both a good embryo and a receptive uterus. AI only evaluates the embryo side
A 2024 multicenter RCT published in The Lancet Digital Health found that AI-assisted embryo selection improved single-embryo transfer pregnancy rates by approximately 10% compared to standard morphological grading. However, cumulative pregnancy rates (across all embryos from a cycle) were similar — suggesting AI helps pick the best embryo first, reducing time-to-pregnancy rather than overall success rates.
Should You Ask for AI Embryo Selection?
The honest answer: it depends on your situation.
💡 AI embryo selection is most valuable when you have multiple good-quality embryos to choose between and want to transfer one at a time. If you only have 1–2 embryos, there's less selection to optimize.
Good candidates for AI selection:
- Patients with multiple blastocysts who want single embryo transfer
- Those choosing not to do PGT-A (AI can help rank embryos, though it doesn't replace genetic testing)
- Clinics without time-lapse incubators — some AI tools work from single images
Less impactful for:
- Patients already doing PGT-A (genetics is a stronger predictor than morphology)
- Patients with only 1–2 embryos (no meaningful selection to make)
- Patients where uterine factors, not embryo quality, are the primary concern
Cost and Availability
AI embryo selection typically adds $500–$2,000 to an IVF cycle. Some clinics include it as part of their standard lab package; others charge separately. Ask your clinic which platform they use, what the additional cost is, and whether any published data supports their specific tool.
Most major US fertility networks (SGF, CCRM, RMA) have adopted some form of AI-assisted selection. Independent clinics vary — it's worth asking during your consultation.
For understanding traditional embryo grading alongside AI scores, see our guide: IVF Embryo Grading Explained.